Ms. Hultberg spent five years with Genentech BioOncology where she effectively launched two new Rituxan indications in CLL and Post Induction Therapy. She was responsible for increasing Rituxan on-label utilization through awareness and advocacy by promoting to Hematologist, Oncologists, Fellows, and Advanced Practitioners in Michigan Clinics and Hospitals. She developed and implemented strategically targeted, account specific business objectives including specific measurable, and action-orientated objectives in accordance with territory goals focused on results.
Prior to Genentech, she was an account executive with Harrison & Star, where she was responsible for relationship management with several major accounts. Ms. Hultberg holds a Bachelor of Arts from the University of Missouri.
Return to Management Team
“…a dedicated, experienced and high-caliber team with the capacity to execute.”